HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

EBV-positive MTX-diffuse large B cell lymphoma in a rheumatoid arthritis patient.

Abstract
Methotrexate (MTX)-associated lymphoproliferative disorders have received much attention from rheumatologists, and early diagnosis is very important for reducing mortality. There are several reports of radiologic findings in patients with pulmonary malignant lymphoma, mainly consisting of masses, nodules, and lymphadenopathy. Computed tomography has rarely detected necrosis in the masses. In this article, we report a case of MTX-associated Epstein-Barr virus-positive diffuse large B-cell lymphoma characterized by a very large lung mass with prominent areas of central necrosis. The disease regressed after withdrawal of MTX.
AuthorsKouhei Tokuyama, Fumito Okada, Shunro Matsumoto, Hiromu Mori, Masao Ogata, Erika Omote, Toru Yamasaki, Syougo Urabe
JournalJapanese journal of radiology (Jpn J Radiol) Vol. 32 Issue 3 Pg. 183-7 (Mar 2014) ISSN: 1867-108X [Electronic] Japan
PMID24408079 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antirheumatic Agents
  • Contrast Media
  • Methotrexate
Topics
  • Aged
  • Antirheumatic Agents (adverse effects, therapeutic use)
  • Arthritis, Rheumatoid (complications, drug therapy)
  • Biopsy
  • Contrast Media
  • Diagnosis, Differential
  • Epstein-Barr Virus Infections (complications, diagnosis)
  • Female
  • Follow-Up Studies
  • Humans
  • In Situ Hybridization (methods)
  • Lymph Nodes (diagnostic imaging, pathology)
  • Lymphoma, Large B-Cell, Diffuse (chemically induced, complications, diagnosis)
  • Methotrexate (adverse effects, therapeutic use)
  • Positron-Emission Tomography (methods)
  • Radiographic Image Enhancement (methods)
  • Tomography, X-Ray Computed (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: